Pain management is one among the branch of drugs which utilizes an inter punitive approach for improving the prevalence and easing the suffering of lifetime of persons who live with the chronic pain. Pain may be a distressing sensory and emotional feeling, which occurs thanks to tissue damage or illness. additionally, various diseases, like MS, osteoarthritis, stomach ulcer, chronic arthritis, fibromyalgia, diabetic neuropathy, and cancer can cause pain.
The duration of pain varies from short term referred to as acute pain to future referred as chronic pain. Acute pain may be a sudden onset of pain, whereas chronic pain occurs thanks to aging conditions of bone & joints, nerve damage, or injury. The management of pain involves decrease or treatment of pain employing a particular set of medicine. Several drugs are available which give pain relief through a spread of physiological mechanism, like by targeting the nociceptors.
The global Pain Management Drugs market is segregated on the basis of Drug Class as NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids, and Nonnarcotic Analgesics. Based on Indication the global Pain Management Drugs market is segmented in Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, and Fibromyalgia.
The global Pain Management Drugs market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Pain Management Drugs market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc., and others are among the major players in the global Pain Management Drugs market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Pain Management Drugs Market has been segmented as below:
Pain Management Drugs Market, By Drug Class
Pain Management Drugs Market, By Indication
Pain Management Drugs Market, By Region
Pain Management Drugs Market, By Company
The report covers:
Report Scope:
The global Pain Management Drugs market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Pain Management Drugs market share. Major industry players with significant revenue share include Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc., and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Pain Management Drugs Market, By Drug Class
5.1 Introduction
5.2 NSAIDs
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Anesthetics
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Anticonvulsants
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Antimigraine Agents
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Antidepressants
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Opioids
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Nonnarcotic Analgesics
5.8.1 Market Overview
5.8.2 Market Size and Forecast
6. Pain Management Drugs Market, By Indication
6.1 Introduction
6.2 Arthritic Pain
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Neuropathic Pain
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Cancer Pain
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Chronic Back Pain
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Postoperative Pain
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Migraine
6.7.1 Market Overview
6.7.2 Market Size and Forecast
6.8 Fibromyalgia
6.8.1 Market Overview
6.8.2 Market Size and Forecast
7. Pain Management Drugs Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Pain Management Drugs, By Drug Class
7.2.2 North America Pain Management Drugs, By Indication
7.3 Europe
7.3.1 Europe Pain Management Drugs, By Drug Class
7.3.2 Europe Pain Management Drugs, By Indication
7.4 Asia-Pacific
7.4.1 Asia-Pacific Pain Management Drugs, By Drug Class
7.4.2 Asia-Pacific Pain Management Drugs, By Indication
7.5 Rest of the World
7.5.1 Rest of the World Pain Management Drugs, By Drug Class
7.5.2 Rest of the World Pain Management Drugs, By Indication
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
(Overview, Key Financials, Recent Developments, Product and Service Offering)
9.1 Novartis AG
9.2 Eli Lilly & Company
9.3 Abbott Laboratories
9.4 Endo Health Solutions, Inc.
9.5 Purdue Pharma L.P.
9.6 Pfizer, Inc.
9.7 F. Hoffmann La Roche Ltd.
9.8 Merck & Co. Inc.
9.9 Johnson & Johnson
9.10 GlaxoSmithKline Plc.
9.11 Depomed, Inc.
9.12 Mallinckrodt Pharmaceuticals
9.13 Teva Pharmaceutical Industries Ltd.
9.14 AstraZeneca plc.
9.15 Merck & Co., Inc.
9.16 GlaxoSmithKline plc.
The Pain Management Drugs Market has been segmented as below:
Pain Management Drugs Market, By Drug Class
Pain Management Drugs Market, By Indication
Pain Management Drugs Market, By Region
Pain Management Drugs Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
